International consensus sets updated framework for CAR T-cell therapy in severe autoimmune diseases

AI Summary

An international panel of 31 specialists has updated consensus recommendations on using CAR T-cell therapy for severe autoimmune diseases that have not responded to other treatments. The framework is intended to guide clinical use in this patient group.

An international multidisciplinary group of 31 experts has updated consensus recommendations to guide the use of CAR T-cell therapy in patients with severe, treatment-refractory autoimmune diseases.